Modulation of the immune system by the gut microbiota in the development of type 1 diabetes
T1D is an autoimmune disease characterized by T cell-mediated destruction of insulin-producing β-cells in the pancreatic islets of Langerhans, resulting in hyperglycemia, with patients requiring lifelong insulin treatment. Many studies have shown that genetics alone are not sufficient for the increa...
Main Authors: | James A. Pearson, Andrew Agriantonis, F. Susan Wong, Li Wen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-11-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2018.1514354 |
Similar Items
-
Inflammasomes and Type 1 Diabetes
by: James Alexander Pearson, et al.
Published: (2021-06-01) -
TLR5-deficiency controls dendritic cell subset development in an autoimmune diabetes-susceptible model
by: James Alexander Pearson, et al.
Published: (2024-02-01) -
Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions
by: James A. Pearson, et al.
Published: (2019-11-01) -
Gut microbiota combined with fecal metabolomics reveals the effects of FuFang Runzaoling on the microbial and metabolic profiles in NOD mouse model of Sjögren’s syndrome
by: Changming Chen, et al.
Published: (2023-06-01) -
Role of gut microbiota in the pathogenesis and treatment of diabetes mullites: Advanced research-based review
by: Junjun Ye, et al.
Published: (2022-10-01)